The Institutional Insight program educates clinicians, patients and their caregivers on the latest advances and treatments in multiple myeloma.
For Clinicians and Healthcare Professionals
The MMRF developed Institutional Insights, a CME symposia series that brings myeloma experts into select cancer centers in the United States. Each symposium features internationally recognized myeloma experts who distill data from the most recent major medical meetings.
Who should attend:
These activities have been designed to meet the educational needs of
- Hematologists
- Medical Oncologists
- Oncology Nurses
- Internists with recently diagnosed patients
Educational Objectives:
At the conclusion of these activities, the participants should be able to:
- Identify the prognostic indicators and diagnostic approaches to multiple myeloma.
- Discuss the latest advances in stem cell transplantation, treatments for bone disease, and supportive care management.
- Describe the role and appropriate use of novel treatments for multiple myeloma throughout the disease progression.
Institutional Insights in Multiple Myeloma, provides practical insight on how to apply the latest advances in diagnosis, prognosis, frontline therapy, treatments for relapsed/refractory disease, management of bone disease, and supportive care.
For Patients and Caregivers
Institutional Insights keeps patients and their caregivers informed about multiple myeloma, new treatments and research. Hear from top myeloma experts; learn about the latest advances in myeloma treatment and care. And, get timely updates on the most promising research in multiple myeloma being conducted today.
The MMRF conducts these physician and patient symposia at top myeloma cancer centers across the country.
To register for an Institutional Insights Clinician or Patient Program, please select an event below.
Upcoming Seminars (click date for details and registration):
Thursday, March 27, 2008 – New York, NY
Institutional Insights in Multiple Myeloma
Institutional Insights in Multiple Myeloma provides practical insight on how to apply the latest advances in diagnosis, prognosis, frontline therapy, treatments for relapsed/refractory disease, management of bone disease and supportive care. Our panel of experts will discuss case studies as they apply to the topics.
Clinician Program
Thursday, March 27th
4:30 PM – 8:00 PM
Grand Hyatt New York
Park Avenue at Grand Central
New York, NY 10017 (
map)
Program Chair:
Sundar Jagannath, MD
St. Vincent's Comprehensive Cancer Center
Chief, Multiple Myeloma Service, Bone Marrow and Stem Cell Transplantation Program
Agenda:
4:30 PM – 5:00 PM
Registration |
5:00 PM – 8:00 PM
Program |
NOTE:
(Dinner will be provided) |
Detailed Agenda:
Thursday, March 27, 2008 – New York, NY
Institutional Insights in Multiple Myeloma provides practical insight on how to apply the latest advances in diagnosis, prognosis, frontline therapy, treatments for relapsed/refractory disease, management of bone disease and supportive care. Our panel of experts will discuss case studies as they apply to the topics.
Patient & Caregiver Program
Multiple myeloma patients and caregivers are encouraged to attend this program. Attendees will learn about the latest findings in research and treatment of multiple myeloma from the leading myeloma experts.
Patient Program
Thursday, March 27th
10:30 AM. - 2:00 PM
Grand Hyatt New York
Park Avenue at Grand Central
New York, NY 10017 (
map)
http://grandnewyork.hyatt.com
Program Chair:
Sundar Jagannath, MD
St. Vincent's Comprehensive Cancer Center
Chief, Multiple Myeloma Service, Bone Marrow and Stem Cell Transplantation Program
Patient Agenda: (revised)
10:30 AM – 11:00 AM
Registration |
11:00 AM – 2:00 PM
Patient & Caregiver Program
Lunch will be provided |
Detailed Agenda:
10:30am – 11:00am Registration
|
11:00 – 11:10 — Welcome & Introduction
Sundar Jagannath, MD
St. Vincent's Comprehensive Cancer Center |
11:10 – 11:35 — Frontline Therapy
Andrzej Jakubowiak, MD
University of Michigan |
11:35 – 12:00 — Transplant
David Vesole, MD
St. Vincent's Comprehensive Cancer Center |
12:00 – 12:25 — Relapsed/Refractory Disease
David Siegel, MD
Hackensack University Medical Center |
12:25 – 12:45 — Break for Lunch
|
12:45 – 1:10 — Supportive Care
G. David Roodman, MD, PhD
University of Pittsburgh Medical Center Hillman Cancer Center |
1:10 – 1:35 — Promising Drugs in Clinical Trials
Sundar Jagannath, MD
St. Vincent's Comprehensive Cancer Center |
1:35 – 2:05 — Panel Q & A
Faculty |
2:05 — Evaluation & Adjourn
Sundar Jagannath, MD
St. Vincent's Comprehensive Cancer Center |
Friday, April 4, 2008 – Los Angeles
Institutional Insights in Multiple Myeloma provides practical insight on how to apply the latest advances in diagnosis, prognosis, frontline therapy, treatments for relapsed/refractory disease, management of bone disease and supportive care. Our panel of experts will discuss case studies as they apply to the topics.
Patient & Caregiver Program
Multiple myeloma patients and caregivers are encouraged to attend this program. Attendees will learn about the latest findings in research and treatment of multiple myeloma from the leading myeloma experts.
Patient Program
Friday, April 4th
8:30 AM – 12:00 PM
Hilton Pasadena
168 South Los Robles Avenue
Pasadena, California (
directions)
Program Chair:
Amrita Krishnan, MD
City of Hope Comprehensive Cancer Center
Associate Professor & Physician, Department of Hematology and Hematopoietic Cell Transplantation;
Associate Director, Medical Education and Training, Division of Hematology and Hematopoietic Cell Transplantation Member
Detailed Agenda:
9:00am – 9:30am — Registration
|
9:30 – 9:40 — Welcome & Introduction
MMRF
|
9:40 – 10:20 — Frontline Therapy/Supportive Care
Keith Stewart, MD
Mayo Clinic |
10:20 – 11:00 — Transplant
Amrita Krishnan, MD
City of Hope |
11:00 – 11:10 — Break
|
11:10 – 11:50 — Relapsed/Refractory Disease/Clinical Trials
Robert Vescio, MD
Cedars–Sinai Medical Center |
11:50 – 12:15 — Panel Q & A
Panel |
12:15 — Evaluation & Adjourn
|
Friday, September 5, 2008 – Atlanta, GA
Institutional Insights in Multiple Myeloma
Institutional Insights in Multiple Myeloma provides practical insight on how to apply the latest advances in diagnosis, prognosis, frontline therapy, treatments for relapsed/refractory disease, management of bone disease and supportive care. Our panel of experts will discuss case studies as they apply to the topics.
Clinician Program
Friday, September 5th
J.W. Marriott Buckhead Atlanta
3300 Lenox Road NE
Atlanta, GA
Program Chair:
Sagar Lonial, MD
The Emory Clinic
Assistant Professor of Hematology and Oncology
Director, Translational Research B-cell Malignancy Program
Agenda:
Detailed Agenda:
Friday, September 5, 2008 &ndash Atlanta
Institutional Insights in Multiple Myeloma provides practical insight on how to apply the latest advances in diagnosis, prognosis, frontline therapy, treatments for relapsed/refractory disease, management of bone disease and supportive care. Our panel of experts will discuss case studies as they apply to the topics.
Patient & Caregiver Program
Multiple myeloma patients and caregivers are encouraged to attend this program. Attendees will learn about the latest findings in research and treatment of multiple myeloma from the leading myeloma experts.
Patient Program
Friday, September 5th
4:00 PM – 8:00 PM
J.W. Marriott Buckhead Atlanta
3300 Lenox Road NE
Atlanta, GA
Program Chair:
Sagar Lonial, MD
The Emory Clinic
Assistant Professor of Hematology and Oncology
Director, Translational Research B-cell Malignancy Program
Detailed Agenda:
Registration
|
Welcome & Introduction
|
Frontline Therapy
|
Transplant
|
Relapsed/Refractory Disease
|
Supportive Care
|
Clinical Trials
|
Panel Q & A
|
Evaluation & Adjourn
|
November 2008
Institutional Insights in Multiple Myeloma provides practical insight on how to apply the latest advances in diagnosis, prognosis, frontline therapy, treatments for relapsed/refractory disease, management of bone disease and supportive care. Our panel of experts will discuss case studies as they apply to the topics.
Patient & Caregiver Program
Multiple myeloma patients and caregivers are encouraged to attend this program. Attendees will learn about the latest findings in research and treatment of multiple myeloma from the leading myeloma experts.
Patient Program
November 2008
?:?? AM – ?:?? PM
TBA
TBA
Tampa, FL
Program Chair:
Mohamad Hussein, MD
H. Lee Moffitt Cancer Center and Research Institute
Leader, Multiple Myeloma Clinical Research
Clinical Director, Malignant Hematology
Patient Agenda: TBA
Detailed Agenda:
Registration
|
Welcome & Introduction
|
Frontline Therapy
|
Transplant
|
Relapsed/Refractory Disease
|
Supportive Care
|
Clinical Trials
|
Panel Q & A
|
Evaluation & Adjourn
|
